TRBD2: A Potential Drug Target for Cancer (G28636)

Target Name: TRBD2

NCBI ID: G28636

Other Name(s): TCRBD2 | T cell receptor beta diversity 2

TRBD2: A Potential Drug Target for Cancer

TRBD2 (Tumor-associated RNA-protein Binding Domain 2) is a protein that is expressed in various tissues of the body, including the brain, spleen, heart, and lymph nodes. It is a member of the RNA-protein binding family, which includes proteins that interact with specific RNA molecules to regulate gene expression.

One of the unique features of TRBD2 is its ability to interact with specific RNA molecules that are expressed in cancer cells. This interaction allows TRBD2 to play a role in the regulation of cancer cell growth, proliferation, and survival.

TRBD2 has also been shown to interact with the protein p21 (T-cell antigen 4), which is a well-known tumor suppressor protein that is often expressed in cancer cells. The interaction between TRBD2 and p21 has been shown to promote the growth and survival of cancer cells, which suggests that TRBD2 may be a potential drug target or biomarker for cancer.

In addition to its interaction with p21, TRBD2 has also been shown to interact with several other proteins that are involved in the regulation of cell growth and differentiation. These interactions may help to further clarify the role of TRBD2 in the regulation of cancer cell growth and differentiation. survival.

Overall, TRBD2 is a protein that has significant potential as a drug target or biomarker for cancer. Further research is needed to fully understand its role in the regulation of cancer cell growth and survival.

Protein Name: T Cell Receptor Beta Diversity 2

More Common Targets